GFA Production Xiamen Co., Ltd. – FDA 483, Dec 8, 2023
GFA Production Xiamen Co., Ltd., a non-sterile drug manufacturer in Xiamen, China, was cited for numerous deficiencies during an FDA inspection. The observations highlight significant data integrity issues, including undocumented testing and disabled audit trails, alongside widespread failures in batch record completeness and control. Further concerns include inadequate microbial control procedures, lack of equipment maintenance, and absence of critical process and cleaning validations, indicating a systemic breakdown in quality assurance.
ID · e69ac240-a296-4168-867b-caa0a40f7e0b
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.